the international society for clinical spectroscopy

Live EstablishedMicroHealthy

the international society for clinical spectroscopy Company Information

Share THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY

Company Number

09664461

Shareholders

-

Group Structure

View All

Industry

Activities of professional membership organisations

 

Registered Address

32 bury avenue, manchester, M16 0AT

the international society for clinical spectroscopy Estimated Valuation

£227.7k

Pomanda estimates the enterprise value of THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY at £227.7k based on a Turnover of £480.6k and 0.47x industry multiple (adjusted for size and gross margin).

the international society for clinical spectroscopy Estimated Valuation

£2k

Pomanda estimates the enterprise value of THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY at £2k based on an EBITDA of £779 and a 2.53x industry multiple (adjusted for size and gross margin).

the international society for clinical spectroscopy Estimated Valuation

£69.4k

Pomanda estimates the enterprise value of THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY at £69.4k based on Net Assets of £28.5k and 2.44x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

The International Society For Clinical Spectroscopy Overview

The International Society For Clinical Spectroscopy is a live company located in manchester, M16 0AT with a Companies House number of 09664461. It operates in the activities of professional membership organizations sector, SIC Code 94120. Founded in June 2015, it's largest shareholder is unknown. The International Society For Clinical Spectroscopy is a established, micro sized company, Pomanda has estimated its turnover at £480.6k with healthy growth in recent years.

View Sample
View Sample
View Sample

The International Society For Clinical Spectroscopy Health Check

Pomanda's financial health check has awarded The International Society For Clinical Spectroscopy a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating1.5out of 5
positive_score

1 Strong

positive_score

3 Regular

positive_score

7 Weak

size

Size

annual sales of £480.6k, make it smaller than the average company (£838.8k)

£480.6k - The International Society For Clinical Spectroscopy

£838.8k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 10%, show it is growing at a similar rate (10.4%)

10% - The International Society For Clinical Spectroscopy

10.4% - Industry AVG

production

Production

with a gross margin of 72%, this company has a comparable cost of product (72%)

72% - The International Society For Clinical Spectroscopy

72% - Industry AVG

profitability

Profitability

an operating margin of 0.2% make it less profitable than the average company (1.1%)

0.2% - The International Society For Clinical Spectroscopy

1.1% - Industry AVG

employees

Employees

with 6 employees, this is below the industry average (12)

6 - The International Society For Clinical Spectroscopy

12 - Industry AVG

paystructure

Pay Structure

on an average salary of £49.6k, the company has an equivalent pay structure (£49.6k)

£49.6k - The International Society For Clinical Spectroscopy

£49.6k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £80.1k, this is less efficient (£111.9k)

£80.1k - The International Society For Clinical Spectroscopy

£111.9k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 16 days, this is earlier than average (23 days)

16 days - The International Society For Clinical Spectroscopy

23 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 0 days, this is quicker than average (28 days)

0 days - The International Society For Clinical Spectroscopy

28 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - The International Society For Clinical Spectroscopy

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 49 weeks, this is less cash available to meet short term requirements (94 weeks)

49 weeks - The International Society For Clinical Spectroscopy

94 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 56.8%, this is a higher level of debt than the average (26.9%)

56.8% - The International Society For Clinical Spectroscopy

26.9% - Industry AVG

THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY financials

EXPORTms excel logo

The International Society For Clinical Spectroscopy's latest turnover from June 2024 is estimated at £480.6 thousand and the company has net assets of £28.5 thousand. According to their latest financial statements, The International Society For Clinical Spectroscopy has 6 employees and maintains cash reserves of £35.5 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016
Turnover480,620335,239387,336356,548414,60787,89080,07548,29029,081
Other Income Or Grants
Cost Of Sales134,53082,87097,889103,784139,57428,20326,27214,3499,169
Gross Profit346,090252,369289,448252,764275,03459,68753,80333,94119,912
Admin Expenses345,310242,895285,169251,238270,79263,80048,31126,21815,779
Operating Profit7809,4744,2791,5264,242-4,1135,4927,7234,133
Interest Payable
Interest Receivable1,7521,40224014127961195
Pre-Tax Profit2,53210,8764,5191,5404,254-4,0345,5537,7424,138
Tax-633-2,719-859-293-808-1,055-1,471-827
Profit After Tax1,8998,1573,6601,2473,446-4,0344,4986,2713,310
Dividends Paid
Retained Profit1,8998,1573,6601,2473,446-4,0344,4986,2713,310
Employee Costs297,547274,629308,176330,772332,00841,03440,70840,94538,804
Number Of Employees667881111
EBITDA*7809,4744,2791,5264,242-4,1135,4927,7234,133

* Earnings Before Interest, Tax, Depreciation and Amortisation

Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016
Tangible Assets
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
Stock & work in progress
Trade Debtors22,1281,5657,077357506,0156,0253,5351,740
Group Debtors
Misc Debtors8,19016,7025,0164,2084,07118,8009,0405,736
Cash35,51831,23424,85513,46714,33310,18310,82313,4401,990
misc current assets138946
total current assets65,83649,50136,94817,71019,29235,94425,88822,7113,730
total assets65,83649,50136,94817,71019,29235,94425,88822,7113,730
Bank overdraft
Bank loan
Trade Creditors 12081,5692,0795,2012,5091,11310
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities37,38122,73816,98189360023,39010,69613,120420
total current liabilities37,38222,94618,5502,9725,80125,89911,80913,130420
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities37,38222,94618,5502,9725,80125,89911,80913,130420
net assets28,45426,55518,39814,73813,49110,04514,0799,5813,310
total shareholders funds28,45426,55518,39814,73813,49110,04514,0799,5813,310
Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016
Operating Activities
Operating Profit7809,4744,2791,5264,242-4,1135,4927,7234,133
Depreciation
Amortisation
Tax-633-2,719-859-293-808-1,055-1,471-827
Stock
Debtors12,0516,1747,850-578-19,9949,7505,7947,5311,740
Creditors-207-1,361-510-3,1222,6921,3961,10310
Accruals and Deferred Income14,6435,75716,088293-22,79012,694-2,42412,700420
Deferred Taxes & Provisions
Cash flow from operations2,5324,97711,148-1,0183,330227-2,67811,4311,986
Investing Activities
capital expenditure
Change in Investments
cash flow from investments
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
interest1,7521,40224014127961195
cash flow from financing1,7521,40224014127961195
cash and cash equivalents
cash4,2846,37911,388-8664,150-640-2,61711,4501,990
overdraft
change in cash4,2846,37911,388-8664,150-640-2,61711,4501,990

the international society for clinical spectroscopy Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for the international society for clinical spectroscopy. Get real-time insights into the international society for clinical spectroscopy's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

The International Society For Clinical Spectroscopy Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for the international society for clinical spectroscopy by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other micro companies, companies in M16 area or any other competitors across 12 key performance metrics.

the international society for clinical spectroscopy Ownership

THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY group structure

The International Society For Clinical Spectroscopy has no subsidiary companies.

Ultimate parent company

THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY

09664461

THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY Shareholders

--

the international society for clinical spectroscopy directors

The International Society For Clinical Spectroscopy currently has 6 directors. The longest serving directors include Mr Peter Gardner (Jun 2015) and Dr Alexander Henderson (Jun 2015).

officercountryagestartendrole
Mr Peter GardnerEngland62 years Jun 2015- Director
Dr Alexander HendersonEngland58 years Jun 2015- Director
Professor Nicholas StoneEngland54 years Jun 2015- Director
Professor Hugh ByrneIreland60 years Jul 2015- Director
Professor Magorzata BaraskaEngland56 years Feb 2017- Director
Professor Bayden WoodEngland58 years Feb 2017- Director

P&L

June 2024

turnover

480.6k

+43%

operating profit

779.8

0%

gross margin

72.1%

-4.35%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

June 2024

net assets

28.5k

+0.07%

total assets

65.8k

+0.33%

cash

35.5k

+0.14%

net assets

Total assets minus all liabilities

the international society for clinical spectroscopy company details

company number

09664461

Type

Private Limited by guarantee without Share Capital Exempt from using Limited

industry

94120 - Activities of professional membership organisations

incorporation date

June 2015

age

10

incorporated

UK

ultimate parent company

None

accounts

Total Exemption Full

last accounts submitted

June 2024

previous names

N/A

accountant

MCKELLENS LIMITED

auditor

-

address

32 bury avenue, manchester, M16 0AT

Bank

-

Legal Advisor

-

the international society for clinical spectroscopy Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to the international society for clinical spectroscopy.

the international society for clinical spectroscopy Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY. This can take several minutes, an email will notify you when this has completed.

the international society for clinical spectroscopy Companies House Filings - See Documents

datedescriptionview/download